Comparative Analysis of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy on Cardiometabolic Health: A Systematic Review and Meta-Analysis of Randomized Trials - Scorecard - MDSpire

Comparative Analysis of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy on Cardiometabolic Health: A Systematic Review and Meta-Analysis of Randomized Trials

  • By

  • Felipe Pereira Garrido Pazos

  • Rafael Matos Vieira Gordilho

  • Eduardo de Oliveira Novelli

  • Luiz Guilherme Lima Santana

  • Maria da Conceição Cavalcanti de Figueiredo Vilaboim

  • Breno Santos Matos de Magalhães

  • Maria Luisa França Lessa

  • Pedro Henrique Matos Oliveira

  • Marcelo Falcão

  • April 29, 2026

  • 0 min

Share

Clinical Scorecard: Comparative Analysis of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy on Cardiometabolic Health: A Systematic Review and Meta-Analysis of Randomized Trials

At a Glance

CategoryDetail
ConditionObesity and its associated cardiometabolic comorbidities
Key MechanismsExcess visceral adiposity leading to insulin resistance, inflammation, and hormonal disturbances
Target PopulationIndividuals with severe obesity
Care SettingBariatric surgical centers

Key Highlights

  • RYGB and SG are effective surgical interventions for severe obesity.
  • Both procedures improve glycemic control, lipid profiles, and blood pressure.
  • Long-term outcomes regarding T2DM remission and inflammatory markers show variability.
  • RYGB has historically been the reference procedure for comparison.
  • SG is the most frequently performed bariatric procedure worldwide.

Guideline-Based Recommendations

Diagnosis

  • Assess obesity through BMI and evaluate comorbidities such as T2DM, hypertension, and dyslipidemia.

Management

  • Consider bariatric surgery for patients with severe obesity and related comorbidities after conservative measures.

Monitoring & Follow-up

  • Regular follow-up on metabolic markers and comorbidity remission post-surgery.

Risks

  • Potential complications include surgical risks and variability in long-term metabolic outcomes.

Patient & Prescribing Data

Patients with severe obesity, particularly those with T2DM, hypertension, and dyslipidemia.

Bariatric surgery leads to significant weight loss and improvements in metabolic health.

Clinical Best Practices

  • Utilize a multidisciplinary approach for preoperative assessment and postoperative care.
  • Educate patients on the potential benefits and risks of RYGB and SG.

References

Original Source(s)

Related Content